Provided by Tiger Trade Technology Pte. Ltd.

Alaunos Therapeutics

3.35
+0.03000.90%
Volume:3.62K
Turnover:11.77K
Market Cap:7.48M
PE:-1.47
High:3.35
Open:3.25
Low:3.12
Close:3.32
52wk High:6.20
52wk Low:1.31
Shares:2.23M
Float Shares:1.91M
Volume Ratio:0.33
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2776
EPS(LYR):-2.9221
ROE:-145.65%
ROA:-69.99%
PB:2.67
PE(LYR):-1.15

Loading ...

Apr 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 17, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 16, 2024

Major Issues Report

Form 8-K - Current report
Jul 16, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report